[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: In the control group, placebo tablets made by Alborz Daru company of Iran with the same shape, color and weight based dose of ivermectin will be used for three days.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: The intervention group will use Iranian standard treatment protocol for COVID-19 in addition to Ivermectin 6 mg oral tablet at a dose of 0.4 mg/kg manufactured by Alborz Daru Co, Iran for 3 days as follows: weight 15-24, 6 mg; Weight 35-25, 12 mg; Weight 50-36, 18 mg; Weight 80-5, 24 mg and weight over 80, 0.4 mg/kg", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: In the control group, placebo tablets made by the Department of Pharmacology of Mazandaran University of Medical Sciences with the same shape, color and weight based dose of ivermectin will be used for three days.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: The intervention group will use Iranian standard treatment protocol for COVID-19 in addition to Ivermectin 3 mg oral tablet at a dose of 0.4 mg/kg manufactured by Europhartech France for 3 days as follows: weight 15-24, 6 mg; Weight 35-25, 12 mg; Weight 50-36, 18 mg; Weight 80-5, 24 mg and weight over 80, 0.4 mg/kg", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]